Summary
- Current Price
- As of today, TAK price is $17.63, up +1.38% on
- Current Price All-Time High
- TAK price is currently -43.66% below its historical high of $31.29 set on
- Market Cap
- TAK current market cap is $56B, up +21.77% over the past 365 days
- Revenue
- TAK current annual revenue is $29.90B, down -0.51% year-over-year
- Next Earnings
- The next earnings release for TAK is on
Profile
| Metric | Value |
|---|---|
| Full Name | Takeda Pharmaceutical Company Limited |
| Ticker | NYSE: TAK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Japan |
| IPO | |
| Indexes | Not included |
| Website | takeda.com |
| Employees | 47,455 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $17.63 | |
| Price, 1D Change | +1.38% | |
| Market Cap | $56B | |
| TTM Dividend Yield | 3.58% | |
| PE Ratio | - | |
| Beta | 0.19 | |
| Revenue | $29.90B | |
| Revenue, 1Y Change | -0.51% | |
| EPS | -$0.32 | |
| EPS, 1Y Change | -245.58% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.31 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | TKPYY | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$0.32 | |
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| Revenue | $29.90B | |
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $17.63 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.32 | - | |
| - | $0.22 | - | |
| - | -$0.32 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $29.49B | - | |
| - | $30.05B | - | |
| - | $29.90B | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +19.12% | |
| Price, 3Y | +15.46% | |
| Market Cap, 1Y | +21.77% | |
| Market Cap, 3Y | +18.59% | |
| Revenue, 1Y | -0.51% | |
| Revenue, 3Y | +0.61% | |
| EPS, 1Y | -245.58% | |
| EPS, 3Y | -143.08% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $17.63 | |
| SMA 200 | $16.43 | |
| SMA 50 | $16.54 | |
| EMA 200 | $16.40 | |
| EMA 50 | $16.85 | |
| MACD | $0.23 | |
| Beta | 0.19 | |
| ATR | $0.32 | |
| 14-Day RSI | 61.44 | |
| 10-Day Volatility | 21.78% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.31 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.58% | |
| Total Dividend | $0.63 | |
| $2.07B | ||
| -205.03% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $29.90B | |
| EPS | -$0.32 | |
| Gross Profit | $15.27B | |
| Gross Margin | 51.06% | |
| Operating Income | $3.59B | |
| Operating Margin | 11.99% | |
| Net Income | -$1.01B | |
| Net Margin | 4.26% | |
| EBITDA | $8.37B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.63 | |
| 1.27 | ||
| 0.70 | ||
| - | ||
| 4 | ||
| 1.24 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 1.88 | ||
| 1.21 | ||
| 9.05 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $48.86B | |
| $3.74B | ||
| $97.50B | ||
| $19.43B | ||
| $50.79B | ||
| $15.27B | ||
| Total Debt | $30.69B | |
| $3.22B | ||
| $3.09B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $28.63B | ||
| $11.68B | ||
| $14.63B | ||
| $0.00 | ||
| $4.79B | ||
| $0.00 | ||
| $452.33M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $6.23B | ||
| -$2.57B | ||
| -$2.49B | ||
| Capex | $2.73B | |
| $3.50B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| TD Cowen | → | |
| TD Cowen | ||
| B of A Securities | → | |
| Cowen & Co. | → | |
| Morgan Stanley | → | |
| JP Morgan | ||
| Cowen & Co. | ||
| Jefferies |
Analyst sentiment
Institutional ownership
Screeners with TAK
FAQ
- What is the ticker symbol for Takeda Pharmaceutical Company Limited?
- The ticker symbol for Takeda Pharmaceutical Company Limited is NYSE:TAK
- Does Takeda Pharmaceutical Company Limited pay dividends?
- Yes, Takeda Pharmaceutical Company Limited pays dividends. The last payment was $0.31, with an ex-dividend date on March 31, 2026
- What sector is Takeda Pharmaceutical Company Limited in?
- Takeda Pharmaceutical Company Limited is in the Healthcare sector
- What industry is Takeda Pharmaceutical Company Limited in?
- Takeda Pharmaceutical Company Limited is in the Specialty & Generic Drug Manufacturers industry
- What country is Takeda Pharmaceutical Company Limited based in?
- Takeda Pharmaceutical Company Limited is headquartered in Japan
- When did Takeda Pharmaceutical Company Limited go public?
- Takeda Pharmaceutical Company Limited initial public offering (IPO) was on January 5, 2010
- Is Takeda Pharmaceutical Company Limited in the S&P 500?
- No, Takeda Pharmaceutical Company Limited is not included in the S&P 500 index
- Is Takeda Pharmaceutical Company Limited in the NASDAQ 100?
- No, Takeda Pharmaceutical Company Limited is not included in the NASDAQ 100 index
- Is Takeda Pharmaceutical Company Limited in the Dow Jones?
- No, Takeda Pharmaceutical Company Limited is not included in the Dow Jones index
- When was Takeda Pharmaceutical Company Limited last earnings report?
- Takeda Pharmaceutical Company Limited's most recent earnings report was on July 30, 2026
- When does Takeda Pharmaceutical Company Limited report earnings?
- The next expected earnings date for Takeda Pharmaceutical Company Limited is October 29, 2026
Data Sources & References
- TAK Official Website www.takeda.com
- TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
- TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak
